To improve quality of health care through the diagnosis and treatment of disease.
To be the most innovative global leader in molecular diagnostics.
Over the next five years, to be the fastest growing and most profitable molecular diagnostics company by both leading the market in HPV testing and in broadly serving the hospital lab segment of the market.